FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

18141411000001109: Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Nov 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62233701000001115 Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62233801000001112 Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Is a Ondansetron 4mg orodispersible tablets true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Is a Product containing precisely ondansetron (as ondansetron hydrochloride) 4 milligram/1 each conventional release orodispersible tablet (clinical drug) false Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Has active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Has specific active ingredient Ondansetron true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) 10 tablet Has AMP True Ondansetron 4mg orodispersible tablets (Phoenix Healthcare Distribution Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start